CMS will require only contract suppliers to furnish bid urological and ostomy supplies nationwide starting by January 1, 2028, with a 6-month transition and remote item delivery. Catheter choice is a ...

ARPIs are being deployed from localized high-risk disease through androgen pathway modulation–resistant states, reflecting durable activity of androgen signaling suppression across clinical contexts.

Availability of estradiol transdermal patches is variable despite ongoing market presence, prompting FDA engagement with all 6 manufacturers to improve continuity of patient therapy. Heightened demand ...